0.06Open0.06Pre Close0 Volume80 Open Interest5.00Strike Price0.00Turnover179.45%IV35.42%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier10DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type-0.0556Delta0.0497Gamma127.50Leverage Ratio-0.0124Theta-0.0001Rho-7.09Eff Leverage0.0014Vega
Treace Medical Concepts Stock Discussion
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
FREY= SHORTED from $1.90s $2s
BNZI= SHORTED from $3.70s SHORTS 🩳 waiting for $4s one last Spike
ELWS= SHORTED from $8s, $7s first entry SHORT
DYXY= SHORTED from $22s
TMCI= SHORTED from $8s
GNLN= SHORTED from $4s
CIFR= SHORTED from $7s
IHRT= SHORTED from $2.80s
$Invesco QQQ Trust (QQQ.US)$ $AMC Entertainment (AMC.US)$ $GameStop (GME.US)$ $NVIDIA (NVDA.US)$ $SPDR S&P 500 ETF (SPY.US)$
Revenue of $45.1 million in third quarter 2024 increased 11% over same period in 2023
•
Third quarter 2024 net loss was ($15.4) million compared to ($17.5) million for same period in 2023. Adjusted EBITDA loss improved 45% to ($5.1) million in the third quarter 2024 compared to ($9.2) million for the same period in 2023
•
Announces first entry into high volume osteotomy market with Nanoplasty™ 3D Minimally Invasive Bunion ...
No comment yet